Logo image
Anticoagulant Treatment
Book chapter

Anticoagulant Treatment

H.P Adams
Encyclopedia of the Neurological Sciences, pp.214-218
Elsevier Inc, Second Edition
2014
DOI: 10.1016/B978-0-12-385157-4.00400-0

View Online

Abstract

Anticoagulants are a component of medical management of patients with ischemic cerebrovascular disease. Parenteral agents, such as heparin or the low-molecular-weight heparins, are of established utility in preventing deep vein thrombosis among bedridden patients with recent stroke. However, they are not useful in lowering the risk of early recurrent stroke, in halting neurological worsening, or in improving neurological outcomes after ischemic stroke. The vitamin K antagonists and thrombin inhibitors lower the risk of thromboembolism among patients with high-risk cardiac diseases, including atrial fibrillation. These agents are not effective in preventing ischemic events secondary to arterial disease.
Stroke prevention Warfarin Vitamin K antagonists Deep vein thrombosis Anticoagulant Low-molecular-weight heparins Heparin Ischemic stroke Thrombin inhibitors Embolism

Details

Metrics

41 Record Views
Logo image